316 related articles for article (PubMed ID: 8865138)
1. Cancer risk in women receiving estrogen-progestin replacement therapy.
Persson I
Maturitas; 1996 May; 23 Suppl():S37-45. PubMed ID: 8865138
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
4. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
Pike MC; Ross RK
Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
[TBL] [Abstract][Full Text] [Related]
5. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
6. Risk of endometrial cancer following estrogen replacement with and without progestins.
Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-progestin replacement therapy and endometrial cancer.
Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
[TBL] [Abstract][Full Text] [Related]
9. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
10. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.
Persson I; Weiderpass E; Bergkvist L; Bergström R; Schairer C
Cancer Causes Control; 1999 Aug; 10(4):253-60. PubMed ID: 10482483
[TBL] [Abstract][Full Text] [Related]
11. Are progestins really necessary as part of a combined HRT regimen?
Sturdee DW
Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281
[TBL] [Abstract][Full Text] [Related]
12. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Ross RK; Paganini-Hill A; Wan PC; Pike MC
J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
[TBL] [Abstract][Full Text] [Related]
13. Progestins and cancer.
Sitruk-Ware R; Plu-Bureau G
Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():3-9. PubMed ID: 12227896
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast.
Ito K
Tohoku J Exp Med; 2007 May; 212(1):1-12. PubMed ID: 17464097
[TBL] [Abstract][Full Text] [Related]
15. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
16. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
Persson I; Yuen J; Bergkvist L; Schairer C
Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
18. Progestins and breast cancer.
Eden J
Am J Obstet Gynecol; 2003 May; 188(5):1123-31. PubMed ID: 12748456
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and endometrial, ovarian and colorectal cancer.
Gambacciani M; Monteleone P; Sacco A; Genazzani AR
Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):139-47. PubMed ID: 12763517
[TBL] [Abstract][Full Text] [Related]
20. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women.
Archer DF
Menopause; 2001; 8(4):245-51. PubMed ID: 11449081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]